Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination

This study in children younger than 5 years, 90% of them between 11 and 23 months, shows a risk of FC similar in magnitude for Priorix-Tetra™ as has previously been reported for ProQuad® suggesting a class effect for these quadrivalent vaccines.